Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ocala, FL
SEC filing record 1 source field available
Fiscal year end
31 December
AIM ImmunoTech Inc. has filed 1,628 SEC EDGAR filings since 14 May 1996

SEC filing history

Showing 926-950 of 1,000 matching filings.

Per page
25
Current page
38
8-K File 000-27072

8-K

Filing date
16 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-205228

424B5

Filing date
16 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-205228

HEBPROSUPPMAXIM12-11X15.HTM

Filing date
15 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Dec 2015
Reporting date
09 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27072

8-K

Filing date
10 Dec 2015
Reporting date
09 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27072

8-K

Filing date
23 Nov 2015
Reporting date
23 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27072

8-K

Filing date
17 Sep 2015
Reporting date
17 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-27072

DEFA14A

Filing date
02 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-27072

DEFA14A

Filing date
01 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-27072

DEFA14A

Filing date
31 Aug 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27072

8-K BLOOD SUPPLY & LITIGATION UPDATE

Filing date
26 Aug 2015
Reporting date
21 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-27072

DEFA14A

Filing date
26 Aug 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Aug 2015
Reporting date
20 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-27072

DEFA14A

Filing date
19 Aug 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Aug 2015
Reporting date
18 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Aug 2015
Reporting date
17 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Aug 2015
Reporting date
13 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-27072

DEF 14A

Filing date
10 Aug 2015
Reporting date
10 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-205228

424B5

Filing date
05 Aug 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-182216

424B5

Filing date
05 Aug 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27072

8-K - MAXIM EDA AMENDMENT

Filing date
05 Aug 2015
Reporting date
04 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-205228

EFFECT filing

Filing date
04 Aug 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
03 Aug 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .